Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Gain Therapeutics (GANX) Asset Utilization Ratio (2021 - 2023)

Gain Therapeutics (GANX) has 3 years of Asset Utilization Ratio data on record, last reported at 0.0 in Q4 2023.

  • For Q4 2023, Asset Utilization Ratio fell 36.87% year-over-year to 0.0; the TTM value through Dec 2023 reached 0.0, down 36.87%, while the annual FY2023 figure was 0.0, 38.55% down from the prior year.
  • Asset Utilization Ratio reached 0.0 in Q4 2023 per GANX's latest filing, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.01 in Q1 2023 and bottomed at 0.0 in Q1 2021.
  • Average Asset Utilization Ratio over 3 years is 0.0, with a median of 0.0 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: soared 309.45% in 2022, then tumbled 42.42% in 2023.
  • A 3-year view of Asset Utilization Ratio shows it stood at 0.0 in 2021, then surged by 98.61% to 0.01 in 2022, then tumbled by 36.87% to 0.0 in 2023.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.0 in Q4 2023, 0.0 in Q3 2023, and 0.0 in Q2 2023.